The phospholipase A2 superfamily and its group numbering system
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dennis, 1994, Diversity of group types, regulation, and function of phospholipase A2, J. Biol. Chem., 269, 13057, 10.1016/S0021-9258(17)36794-7
Dennis, 1997, The growing phospholipase A2 superfamily of signal transduction enzymes, Trends Biochem. Sci., 22, 1, 10.1016/S0968-0004(96)20031-3
Six, 2000, The expanding superfamily of phospholipase A2 enzymes: classification and characterization, Biochim. Biophys. Acta, 1488, 1, 10.1016/S1388-1981(00)00105-0
Balsinde, 2002, Phospholipase A2 regulation of arachidonic acid mobilization, FEBS Lett., 531, 2, 10.1016/S0014-5793(02)03413-0
Ohto, 2005, Identification of novel cytosolic phospholipase A2s, murine cPLA2 delta, epsilon, and zeta, which form a gene cluster with cPLA2 beta, J. Biol. Chem., 280, 24576, 10.1074/jbc.M413711200
Jenkins, 2004, Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities, J. Biol. Chem., 279, 48968, 10.1074/jbc.M407841200
van Tienhoven, 2002, Human neuropathy target esterase catalyzes hydrolysis of membrane lipids, J. Biol. Chem., 277, 20942, 10.1074/jbc.M200330200
Abe, 1998, Purification and characterization of 1-O-acylceramide synthase, a novel phospholipase A2 with transacylase activity, J. Biol. Chem., 273, 8467, 10.1074/jbc.273.14.8467
Hiraoka, 2002, Cloning and characterization of a lysosomal phospholipase A2, 1-O-acylceramide synthase, J. Biol. Chem., 277, 10090, 10.1074/jbc.M111977200
Hiraoka, 2006, Lysosomal phospholipase A2 and phospholipidosis, Mol. Cell. Biol., 26, 6139, 10.1128/MCB.00627-06
Funk, 2001, Prostaglandins and leukotrienes: advances in eicosanoid biology, Science, 294, 1871, 10.1126/science.294.5548.1871
Tsuboi, 2002, Prostanoid receptor subtypes, Prostaglandins Other Lipid Mediators, 68–69, 535, 10.1016/S0090-6980(02)00054-0
Moolenaar, 2004, The ins and outs of lysophosphatidic acid signaling, BioEssays, 26, 870, 10.1002/bies.20081
Prescott, 2000, Platelet-activating factor and related lipid mediators, Annu. Rev. Biochem., 69, 419, 10.1146/annurev.biochem.69.1.419
Singer, 2002, Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2, J. Biol. Chem., 277, 48535, 10.1074/jbc.M205855200
Lee, 2005, Multiple forms of secretory phospholipase A2 in plants, Prog. Lipid Res., 44, 52, 10.1016/j.plipres.2004.10.002
Kuchler, 1989, Analysis of the cDNA for phospholipase A2 from honeybee venom glands. The deduced amino acid sequence reveals homology to the corresponding vertebrate enzymes, Eur. J. Biochem., 184, 249, 10.1111/j.1432-1033.1989.tb15014.x
Ryu, 2003, Molecular characterization of a gene encoding the Drosophila melanogaster phospholipase A2, Biochim. Biophys. Acta, 1628, 206, 10.1016/S0167-4781(03)00143-X
McIntosh, 1995, Conodipine-M, a novel phospholipase A2 isolated from the venom of the marine snail conus magus, J. Biol. Chem., 270, 3518, 10.1074/jbc.270.8.3518
Manjunatha Kini, 2003, Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes, Toxicon, 42, 827, 10.1016/j.toxicon.2003.11.002
Valentin, 2000, Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteins, Biochim. Biophys. Acta, 1488, 59, 10.1016/S1388-1981(00)00110-4
Zadori, 2001, A viral phospholipase A2 is required for parvovirus infectivity, Dev. Cell, 1, 291, 10.1016/S1534-5807(01)00031-4
Canaan, 2004, Interfacial enzymology of parvovirus phospholipases A2, J. Biol. Chem., 279, 14502, 10.1074/jbc.M312630200
Miozzi, 2005, Phospholipase A2 up-regulation during mycorrhiza formation in Tuber borchii, New Phytol., 167, 229, 10.1111/j.1469-8137.2005.01400.x
Soragni, 2001, A nutrient-regulated, dual localization phospholipase A2 in the symbiotic fungus Tuber borchii, EMBO J., 20, 5079, 10.1093/emboj/20.18.5079
Sugiyama, 2002, A novel prokaryotic phospholipase A2. Characterization, gene cloning, and solution structure, J. Biol. Chem., 277, 20051, 10.1074/jbc.M200264200
Matoba, 2002, The crystal structure of prokaryotic phospholipase A2, J. Biol. Chem., 277, 20059, 10.1074/jbc.M200263200
Valentin, 2000, Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme, J. Biol. Chem., 275, 7492, 10.1074/jbc.275.11.7492
Murakami, 2003, Cellular arachidonate-releasing function of novel classes of secretory phospholipase A2s (groups III and XII), J. Biol. Chem., 278, 10657, 10.1074/jbc.M211325200
Reddy, 1996, Transcellular prostaglandin production following mast cell activation is mediated by proximal secretory phospholipase A2 and distal prostaglandin synthase 1, J. Biol. Chem., 271, 186, 10.1074/jbc.271.1.186
Murakami, 1999, Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways, J. Biol. Chem., 274, 3103, 10.1074/jbc.274.5.3103
Wijewickrama, 2006, Systematic evaluation of transcellular activities of secretory phospholipases A2: high activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring inflammatory cells, J. Biol. Chem., 281, 10935, 10.1074/jbc.M512657200
Mounier, 2004, Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A2 occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A2-alpha, J. Biol. Chem., 279, 25024, 10.1074/jbc.M313019200
Seilhamer, 1989, Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid, J. Biol. Chem., 264, 5335, 10.1016/S0021-9258(18)83549-9
Nevalainen, 2000, Roles of secretory phospholipases A2 in inflammatory diseases and trauma, Biochim. Biophys. Acta, 1488, 83, 10.1016/S1388-1981(00)00112-8
Pruzanski, 2005, Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2, Biochim. Biophys. Acta, 1736, 38
Boyanovsky, 2005, Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans, J. Biol. Chem., 280, 32746, 10.1074/jbc.M502067200
Wooton-Kee, 2004, Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation, Arterioscler., Thromb., Vasc. Biol., 24, 762, 10.1161/01.ATV.0000122363.02961.c1
Murakami, 2003, New phospholipase A2 isozymes with a potential role in atherosclerosis, Curr. Opin. Lipidol., 14, 431, 10.1097/00041433-200310000-00003
Webb, 2005, Secretory phospholipase A2 enzymes in atherogenesis, Curr. Opin. Lipidol., 16, 341, 10.1097/01.mol.0000169355.20395.55
Wei, 2003, Group IIA secretory phospholipase A2 stimulates exocytosis and neurotransmitter release in pheochromocytoma-12 cells and cultured rat hippocampal neurons, Neuroscience, 121, 891, 10.1016/S0306-4522(03)00525-6
Juhl, 2003, Secretory phospholipase A2 is released from pancreatic beta-cells and stimulates insulin secretion via inhibition of ATP-dependent K+ channels, Biochem. Biophys. Res. Commun., 310, 274, 10.1016/j.bbrc.2003.09.018
Enomoto, 2000, Redundant and segregated functions of granule-associated heparin-binding group II subfamily of secretory phospholipases A2 in the regulation of degranulation and prostaglandin D2 synthesis in mast cells, J. Immunol., 165, 4007, 10.4049/jimmunol.165.7.4007
Kini, 2005, Structure–function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms, Toxicon, 45, 1147, 10.1016/j.toxicon.2005.02.018
Mounier, 2001, Anticoagulant venom and mammalian secreted phospholipases A2: protein- versus phospholipid-dependent mechanism of action, Haemostasis, 31, 279
Koduri, 2002, Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2, J. Biol. Chem., 277, 5849, 10.1074/jbc.M109699200
Beers, 2002, The antibacterial properties of secreted phospholipases A2. A major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall, J. Biol. Chem., 277, 1788, 10.1074/jbc.M109777200
Satake, 2004, Role of Group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption, J. Biol. Chem., 279, 16488, 10.1074/jbc.M313748200
Gijon, 2000, Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that Do and Do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation, J. Biol. Chem., 275, 20146, 10.1074/jbc.M908941199
Munoz, 2003, Human group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophils, J. Biol. Chem., 278, 38813, 10.1074/jbc.M302476200
Mitsuishi, 2006, Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells, Biochem. J., 393, 97, 10.1042/BJ20050781
Laye, 2003, Phospholipase A2 expression in tumours: a target for therapeutic intervention?, Drug Discovery Today, 8, 710, 10.1016/S1359-6446(03)02754-5
Svensson, 2005, Spinal phospholipase A2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A2, Neuroscience, 133, 543, 10.1016/j.neuroscience.2005.01.024
Lappas, 2004, Phospholipase A2 isozymes in pregnancy and parturition, Prostaglandins, Leukotrienes Essent. Fatty Acids, 70, 87, 10.1016/j.plefa.2003.04.001
Hanasaki, 2002, Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2, Prostaglandins Other Lipid Mediators, 68–69, 71, 10.1016/S0090-6980(02)00022-9
Triggiani, 2002, Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes, Eur. J. Immunol., 32, 67, 10.1002/1521-4141(200201)32:1<67::AID-IMMU67>3.0.CO;2-3
Triggiani, 2003, Secretory phospholipases A2 activate selective functions in human eosinophils, J. Immunol., 170, 3279, 10.4049/jimmunol.170.6.3279
Granata, 2005, Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor, J. Immunol., 174, 464, 10.4049/jimmunol.174.1.464
Fonteh, 2001, Enhancement of mast cell survival: a novel function of some secretory phospholipase A2 isotypes, J. Immunol., 167, 4161, 10.4049/jimmunol.167.8.4161
Fonteh, 2000, Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells, J. Immunol., 165, 2773, 10.4049/jimmunol.165.5.2773
Mandal, 2001, Pancreatic phospholipase A2 via its receptor regulates expression of key enzymes of phospholipid and sphingolipid metabolism, FASEB J., 15, 1834, 10.1096/fj.00-0831fje
Rouault, 2003, Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity, Biochemistry, 42, 11494, 10.1021/bi0349930
Glover, 1995, Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen, J. Biol. Chem., 270, 15359, 10.1074/jbc.270.25.15359
Peters-Golden, 1996, Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis, Biochem. J., 318, 797, 10.1042/bj3180797
Hirabayashi, 1999, Critical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A2, J. Biol. Chem., 274, 5163, 10.1074/jbc.274.8.5163
Evans, 2001, Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes, J. Biol. Chem., 276, 30150, 10.1074/jbc.M100943200
Evans, 2004, The cytosolic phospholipase A2 catalytic domain modulates association and residence time at Golgi membranes, J. Biol. Chem., 279, 6005, 10.1074/jbc.M311246200
Shirai, 2005, Localization and functional interrelationships among cytosolic Group IV, secreted Group V, and Ca2+-independent Group VI phospholipase A2s in P388D1 macrophages using GFP/RFP constructs, Biochim. Biophys. Acta, 1735, 119, 10.1016/j.bbalip.2005.05.005
Qiu, 1993, Regulation of phospholipase A2 activation by phosphorylation in mouse peritoneal macrophages, J. Biol. Chem., 268, 24506, 10.1016/S0021-9258(20)80554-7
de Carvalho, 1996, Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes, J. Biol. Chem., 271, 6987, 10.1074/jbc.271.12.6987
Qiu, 1998, The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachidonic acid release in macrophages, J. Biol. Chem., 273, 8203, 10.1074/jbc.273.14.8203
Borsch-Haubold, 1998, Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells, J. Biol. Chem., 273, 4449, 10.1074/jbc.273.8.4449
Hefner, 2000, Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases, J. Biol. Chem., 275, 37542, 10.1074/jbc.M003395200
Leslie, 1991, Kinetic properties of a high molecular mass arachidonoyl-hydrolyzing phospholipase A2 that exhibits lysophospholipase activity, J. Biol. Chem., 266, 11366, 10.1016/S0021-9258(18)99172-6
Reynolds, 1993, Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2, Biochim. Biophys. Acta, 1167, 272, 10.1016/0005-2760(93)90229-3
Leslie, 1990, Anionic phospholipids stimulate an arachidonoyl-hydrolyzing phospholipase A2 from macrophages and reduce the calcium requirement for activity, Biochim. Biophys. Acta, 1045, 261, 10.1016/0005-2760(90)90129-L
Mosior, 1998, Group IV cytosolic phospholipase A2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity, J. Biol. Chem., 273, 2184, 10.1074/jbc.273.4.2184
Six, 2003, Essential Ca2+-independent role of the group IVA cytosolic phospholipase A2 C2 domain for interfacial activity, J. Biol. Chem., 278, 23842, 10.1074/jbc.M301386200
Das, 2002, Roles of catalytic domain residues in interfacial binding and activation of group IV cytosolic phospholipase A2, J. Biol. Chem., 277, 23838, 10.1074/jbc.M202322200
Balsinde, 2000, Cellular regulation of cytosolic group IV phospholipase A2 by phosphatidylinositol bisphosphate levels, J. Immunol., 164, 5398, 10.4049/jimmunol.164.10.5398
Casas, 2006, Phosphatidylinositol 4,5-bisphosphate anchors cytosolic Group IVA phospholipase A2 to perinuclear membranes and decreases its calcium requirement for translocation in live cells, Mol. Biol. Cell, 17, 155, 10.1091/mbc.e05-06-0545
Uozumi, 1997, Role of cytosolic phospholipase A2 in allergic response and parturition, Nature, 390, 618, 10.1038/37622
Bonventre, 1997, Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2, Nature, 390, 622, 10.1038/37635
Uozumi, 2002, Roles for cytosolic phospholipase A2 alpha as revealed by gene-targeted mice, Prostaglandins Other Lipid Mediators, 68–69, 59, 10.1016/S0090-6980(02)00021-7
Lucas, 2005, Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2, Br. J. Pharmacol., 144, 940, 10.1038/sj.bjp.0706116
Song, 1999, Molecular characterization of cytosolic phospholipase A2-beta, J. Biol. Chem., 274, 17063, 10.1074/jbc.274.24.17063
Pickard, 1999, Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2, J. Biol. Chem., 274, 8823, 10.1074/jbc.274.13.8823
Underwood, 1998, A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2, J. Biol. Chem., 273, 21926, 10.1074/jbc.273.34.21926
Tucker, 2005, Group IVC cytosolic phospholipase A2 gamma is farnesylated and palmitoylated in mammalian cells, J. Lipid Res., 46, 2122, 10.1194/jlr.M500230-JLR200
Lucas, 2004, The ABC's of Group IV cytosolic phospholipase A2, Biochim. Biophys. Acta, 1636, 213, 10.1016/j.bbalip.2003.12.009
Stewart, 2002, Enzymatic properties of human cytosolic phospholipase A2 gamma, J. Biol. Chem., 277, 29526, 10.1074/jbc.M204856200
Chiba, 2004, Cloning of a gene for a novel epithelium-specific cytosolic phospholipase A2, cPLA2 delta, induced in psoriatic skin, J. Biol. Chem., 279, 12890, 10.1074/jbc.M305801200
Dessen, 2000, Structure and mechanism of human cytosolic phospholipase A2, Biochim. Biophys. Acta, 1488, 40, 10.1016/S1388-1981(00)00108-6
Hirabayashi, 2004, Regulatory mechanism and physiological role of cytosolic phospholipase A2, Biol. Pharm. Bull., 27, 1168, 10.1248/bpb.27.1168
Leslie, 2004, Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2, Prostaglandins, Leukotrienes Essent. Fatty Acids, 70, 373, 10.1016/j.plefa.2003.12.012
Diaz, 2002, Participation of cytosolic phospholipase A2 in eicosanoid generation by mouse bone marrow-derived mast cells, Adv. Exp. Med. Biol., 507, 41, 10.1007/978-1-4615-0193-0_7
Bonventre, 2002, Group IV cytosolic phospholipase A2 (PLA2) function: insights from the knockout mouse, Adv. Exp. Med. Biol., 507, 25, 10.1007/978-1-4615-0193-0_5
Evans, 2003, Regulation of cytosolic phospholipase A2 translocation, Adv. Enzyme Regul., 43, 229, 10.1016/S0065-2571(02)00034-1
Ackermann, 1994, Ca2+-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization, J. Biol. Chem., 269, 9227, 10.1016/S0021-9258(17)37098-9
Tang, 1997, A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs, J. Biol. Chem., 272, 8567, 10.1074/jbc.272.13.8567
Larsson, 1998, Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity, J. Biol. Chem., 273, 207, 10.1074/jbc.273.1.207
Lio, 1998, Interfacial activation, lysophospholipase and transacylase activity of group VI Ca2+-independent phospholipase A2, Biochim. Biophys. Acta, 1392, 320, 10.1016/S0005-2760(98)00049-6
Balsinde, 1995, Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages, Proc. Natl. Acad. Sci. U. S. A., 92, 8527, 10.1073/pnas.92.18.8527
Rickard, 2005, Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells, Am. J. Physiol.: Renal, Physiol., 288, F714
Perez, 2004, Role of Group VIA calcium-independent phospholipase A2 in arachidonic acid release, phospholipid fatty acid incorporation, and apoptosis in U937 cells responding to hydrogen peroxide, J. Biol. Chem., 279, 40385, 10.1074/jbc.M402562200
Yellaturu, 2003, A requirement for calcium-independent phospholipase A2 in thrombin-induced arachidonic acid release and growth in vascular smooth muscle cells, J. Biol. Chem., 278, 43831, 10.1074/jbc.M301472200
Martinez, 2001, Role of Ca2+-independent phospholipase A2 on arachidonic acid release induced by reactive oxygen species, Arch. Biochem. Biophys., 392, 257, 10.1006/abbi.2001.2439
Atsumi, 1998, Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation, J. Biol. Chem., 273, 13870, 10.1074/jbc.273.22.13870
Moran, 2005, Genetic and pharmacologic evidence that calcium-independent phospholipase A2 beta regulates virus-induced inducible nitric-oxide synthase expression by macrophages, J. Biol. Chem., 280, 28162, 10.1074/jbc.M500013200
Seegers, 2002, Calcium-independent phospholipase A2-derived arachidonic acid is essential for endothelium-dependent relaxation by acetylcholine, J. Pharmacol. Exp. Ther., 302, 918, 10.1124/jpet.302.3.918
Song, 2005, Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance, Mol. Endocrinol., 19, 504, 10.1210/me.2004-0169
Balboa, 2003, Calcium-independent phospholipase A2 is required for lysozyme secretion in U937 promonocytes, J. Immunol., 170, 5276, 10.4049/jimmunol.170.10.5276
Ma, 2001, Studies of insulin secretory responses and of arachidonic acid incorporation into phospholipids of stably transfected insulinoma cells that overexpress Group VIA phospholipase A2 (iPLA2 beta) indicate a signaling rather than a housekeeping role for iPLA2 beta, J. Biol. Chem., 276, 13198, 10.1074/jbc.M010423200
Atsumi, 2000, Distinct roles of two intracellular phospholipase A2s in fatty acid release in the cell death pathway. Proteolytic fragment of type IVA cytosolic phospholipase A2 alpha inhibits stimulus-induced arachidonate release, whereas that of type VI Ca2+-independent phospholipase A2 augments spontaneous fatty acid release, J. Biol. Chem., 275, 18248, 10.1074/jbc.M000271200
Perez, 2006, Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells, J. Lipid Res., 47, 484, 10.1194/jlr.M500397-JLR200
Perez, 2006, Involvement of Group VIA calcium-independent phospholipase A2 in macrophage engulfment of hydrogen peroxide-treated U937 cells, J. Immunol., 176, 2555, 10.4049/jimmunol.176.4.2555
Mancuso, 2003, Cardiac ischemia activates calcium-independent phospholipase A2 beta, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition, J. Biol. Chem., 278, 22231, 10.1074/jbc.C300033200
Roshak, 2000, Human calcium-independent phospholipase A2 mediates lymphocyte proliferation, J. Biol. Chem., 275, 35692, 10.1074/jbc.M002273200
Manguikian, 2004, Cell cycle dependence of group VIA calcium-independent phospholipase A2 activity, J. Biol. Chem., 279, 52881, 10.1074/jbc.M410659200
Bolotina, 2005, CIF and other mysteries of the store-operated Ca2+-entry pathway, Trends Biochem. Sci., 30, 378, 10.1016/j.tibs.2005.05.009
Winstead, 2000, Calcium-independent phospholipase A2: structure and function, Biochim. Biophys. Acta, 1488, 28, 10.1016/S1388-1981(00)00107-4
Balsinde, 2005, Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells, Cell Signalling, 17, 1052, 10.1016/j.cellsig.2005.03.002
Akiba, 2004, Cellular function of calcium-independent phospholipase A2, Biol. Pharm. Bull., 27, 1174, 10.1248/bpb.27.1174
Turk, 2004, The expression and function of a group VIA calcium-independent phospholipase A2 (iPLA2 beta) in beta-cells, Can. J. Physiol. Pharmacol., 82, 824, 10.1139/y04-064
Mancuso, 2000, The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A2, J. Biol. Chem., 275, 9937, 10.1074/jbc.275.14.9937
Murakami, 2005, Group VIB Ca2+-independent phospholipase A2 gamma promotes cellular membrane hydrolysis and prostaglandin production in a manner distinct from other intracellular phospholipases A2, J. Biol. Chem., 280, 14028, 10.1074/jbc.M413766200
Jenkins, 2002, Identification of calcium-independent phospholipase A2 (iPLA2) beta, and not iPLA2 gamma , as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammalian iPLA2s, J. Biol. Chem., 277, 32807, 10.1074/jbc.M202568200
Glynn, 2005, Neuropathy target esterase and phospholipid deacylation, Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, 1736, 87
Min, 1999, Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase, Biochemistry, 38, 12935, 10.1021/bi991149u
Karasawa, 2003, Plasma platelet activating factor-acetylhydrolase (PAF-AH), Prog. Lipid Res., 42, 93, 10.1016/S0163-7827(02)00049-8
Chen, 2004, Platelet-activating factor acetylhydrolase: is it good or bad for you?, Curr. Opin. Lipidol., 15, 337, 10.1097/00041433-200406000-00015
Caslake, 2003, Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease, Curr. Opin. Lipidol., 14, 347, 10.1097/00041433-200308000-00002
Zalewski, 2005, Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target, Arterioscler., Thromb., Vasc. Biol., 25, 923, 10.1161/01.ATV.0000160551.21962.a7
Blackie, 2003, The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2, Bioorg. Med. Chem. Lett., 13, 1067, 10.1016/S0960-894X(03)00058-1
Matsuzawa, 1997, Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II, J. Biol. Chem., 272, 32315, 10.1074/jbc.272.51.32315
Manya, 1999, Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase, J. Biol. Chem., 274, 31827, 10.1074/jbc.274.45.31827
Hattori, 1995, Cloning and expression of a cDNA encoding the beta-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase, J. Biol. Chem., 270, 31345, 10.1074/jbc.270.52.31345
Morris, 2000, Nuclear migration. From fungi to the mammalian brain, J. Cell Biol., 148, 1097, 10.1083/jcb.148.6.1097
Manya, 1998, Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain, J. Biol. Chem., 273, 18567, 10.1074/jbc.273.29.18567
Yang, 1999, Group-specific assays that distinguish between the four major types of mammalian phospholipase A2, Anal. Biochem., 269, 278, 10.1006/abio.1999.4053
Lucas, 2005, Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors, Prostaglandins Other Lipid Mediators, 77, 235, 10.1016/j.prostaglandins.2005.02.004
Leslie, 2004, Assaying phospholipase A2 activity, Methods Mol. Biol., 284, 229
Smart, 2004, Inhibition of the complete set of mammalian secreted phospholipases A2 by indole analogues: a structure-guided study, Bioorg. Med. Chem., 12, 1737, 10.1016/j.bmc.2004.01.022
Schevitz, 1995, Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2, Nat. Struct. Biol., 2, 458, 10.1038/nsb0695-458
Suzuki, 2000, Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A2s, J. Biol. Chem., 275, 5785, 10.1074/jbc.275.8.5785
Yokota, 2000, Identification of group X secretory phospholipase A2 as a natural ligand for mouse phospholipase A2 receptor, FEBS Lett., 478, 187, 10.1016/S0014-5793(00)01848-2
Yokota, 1999, Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms, Biochim. Biophys. Acta, 1438, 213, 10.1016/S1388-1981(99)00053-0
Reid, 2005, Inhibitors of secretory phospholipase A2 group IIA, Curr. Med. Chem., 12, 3011, 10.2174/092986705774462860
Lio, 1996, Irreversible inhibition of Ca2+-independent phospholipase A2 by methyl arachidonyl fluorophosphonate, Biochim. Biophys. Acta, 1302, 55, 10.1016/0005-2760(96)00002-1
De Petrocellis, 1997, Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase, Biochem. Biophys. Res. Commun., 231, 82, 10.1006/bbrc.1997.6000
Deutsch, 1997, Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase, Biochem. Pharmacol., 53, 255, 10.1016/S0006-2952(96)00830-1
Kell, 2003, Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells, J. Pharmacol. Exp. Ther., 307, 1163, 10.1124/jpet.103.055392
Fernando, 1997, Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist, Br. J. Pharmacol., 121, 1716, 10.1038/sj.bjp.0701303
Riendeau, 1994, Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12- hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets, J. Biol. Chem., 269, 15619, 10.1016/S0021-9258(17)40726-5
Ono, 2002, Characterization of a novel inhibitor of cytosolic phospholipase A2 alpha, pyrrophenone, Biochem. J., 363, 727, 10.1042/bj3630727
Balboa, 2003, Amplification mechanisms of inflammation: paracrine stimulation of arachidonic acid mobilization by secreted phospholipase A2 Is regulated by cytosolic phospholipase A2-derived hydroperoxyeicosatetraenoic acid, J. Immunol., 171, 989, 10.4049/jimmunol.171.2.989
Saiga, 2005, Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 alpha, Prostaglandins Other Lipid Mediators, 75, 79, 10.1016/j.prostaglandins.2004.10.001
Kessen, 2005, PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS, J. Lipid Res., 46, 2488, 10.1194/jlr.M500325-JLR200
Ghomashchi, 2001, A pyrrolidine-based specific inhibitor of cytosolic phospholipase A2 alpha blocks arachidonic acid release in a variety of mammalian cells, Biochim. Biophys. Acta, 1513, 160, 10.1016/S0005-2736(01)00349-2
Balsinde, 1996, Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages, J. Biol. Chem., 271, 31937, 10.1074/jbc.271.50.31937
Johnson, 1999, Regulation of cyclooxygenase-2 expression by phosphatidate phosphohydrolase in human amnionic WISH cells, J. Biol. Chem., 274, 27689, 10.1074/jbc.274.39.27689
Kennedy, 1995, A natural disruption of the secretory Group II phospholipase A2 gene in inbred mouse strains, J. Biol. Chem., 270, 22378, 10.1074/jbc.270.38.22378
Kihara, 2005, Natural disruption of group 2 phospholipase A2 gene protects against choline-deficient ethionine-supplemented diet-induced acute pancreatitis and lung injury, Pancreas, 31, 48, 10.1097/01.mpa.0000168223.43709.28
Reddy, 1997, Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells, J. Biol. Chem., 272, 13591, 10.1074/jbc.272.21.13591
Tischfield, 1997, A reassessment of the low molecular weight phospholipase A2 gene family in mammals, J. Biol. Chem., 272, 17247, 10.1074/jbc.272.28.17247
Balestrieri, 2006, Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis, J. Biol. Chem., 281, 6691, 10.1074/jbc.M508314200
Huggins, 2002, Protection against diet-induced obesity and obesity- related insulin resistance in Group 1B PLA2-deficient mice, Am. J. Physiol.: Endocrinol. Metab., 283, E994
Bao, 2004, Male mice that do not express Group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility, J. Biol. Chem., 279, 38194, 10.1074/jbc.M406489200
Koizumi, 2003, Targeted disruption of intracellular type I platelet activating factor-acetylhydrolase catalytic subunits causes severe impairment in spermatogenesis, J. Biol. Chem., 278, 12489, 10.1074/jbc.M211836200
Juhl, 2003, cPLA2 alpha-evoked formation of arachidonic acid and lysophospholipids is required for exocytosis in mouse pancreatic beta-cells, Am. J. Physiol.: Endocrinol. Metab., 285, E73
Tommasini, 2004, Dexamethasone promotes toxicity in U937 cells exposed to otherwise nontoxic concentrations of peroxynitrite: pivotal role for lipocortin 1-mediated inhibition of cytosolic phospholipase A2, Mol. Pharmacol., 65, 964, 10.1124/mol.65.4.964
Li, 2005, Angiotensin II-induced Akt activation is mediated by metabolites of arachidonic acid generated by CaMKII-stimulated Ca2+-dependent phospholipase A2, Am. J. Physiol.: Heart Circ. Physiol., 288, H2306
Kriem, 2005, Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide, FASEB J., 19, 85, 10.1096/fj.04-1807fje
Guidarelli, 2005, A downstream role for protein kinase C alpha in the cytosolic phospholipase A2-dependent protective signalling mediated by peroxynitrite in U937 cells, Biochem. Pharmacol., 69, 1275, 10.1016/j.bcp.2005.02.002
Dong, 2005, Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis, Clin. Cancer Res., 11, 2265, 10.1158/1078-0432.CCR-04-1079
Han, 2002, 85-kDa cPLA2 plays a critical role in PPAR-mediated gene transcription in human hepatoma cells, Am. J. Physiol.: Gastrointest. Liver Physiol., 282, G586
Yoo, 2001, Role of the cytosolic phospholipase A2-linked cascade in signaling by an oncogenic, constitutively active Ha-Ras isoform, J. Biol. Chem., 276, 24645, 10.1074/jbc.M101975200
Zhao, 2002, Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67phox and p47phox, J. Biol. Chem., 277, 25385, 10.1074/jbc.M203630200
Burgermeister, 2000, Inhibition of cytosolic phospholipase A2 attenuates activation of mitogen-activated protein kinases in human monocytic cells, Eur. J. Pharmacol., 388, 195, 10.1016/S0014-2999(99)00816-X
Balboa, 1996, Novel Group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages, J. Biol. Chem., 271, 32381, 10.1074/jbc.271.50.32381
Balsinde, 1997, Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages, J. Biol. Chem., 272, 29317, 10.1074/jbc.272.46.29317
Carnevale, 2001, Calcium-independent phospholipase A2 is required for human monocyte chemotaxis to monocyte chemoattractant protein 1, J. Immunol., 167, 3414, 10.4049/jimmunol.167.6.3414
Balboa, 2002, Involvement of calcium-independent phospholipase A2 in hydrogen peroxide-induced accumulation of free fatty acids in human U937 cells, J. Biol. Chem., 277, 40384, 10.1074/jbc.M206155200
Sanchez, 2002, Calcium-independent phospholipase A2 through arachidonic acid mobilization is involved in Caco-2 cell growth, J. Cell. Physiol., 193, 293, 10.1002/jcp.10162
Urban, 2003, Structural modifications of antisense oligonucleotides, Il Farmaco, 58, 243, 10.1016/S0014-827X(03)00022-3
Koller, 2000, Elucidating cell signaling mechanisms using antisense technology, Trends Pharmacol. Sci., 21, 142, 10.1016/S0165-6147(00)01448-6
Baker, 2001, Discovery and analysis of antisense oligonucleotide activity in cell culture, Methods, 23, 191, 10.1006/meth.2000.1120
Kurreck, 2003, Antisense technologies. Improvement through novel chemical modifications, Eur. J. Biochem., 270, 1628, 10.1046/j.1432-1033.2003.03555.x
Levin, 1999, A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides, Biochim. Biophys. Acta, 1489, 69, 10.1016/S0167-4781(99)00140-2
Bao, 2005, Effects of stable suppression of group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells, J. Biol. Chem., 281, 187, 10.1074/jbc.M509105200
Su, 2004, Small interfering RNA knockdown of calcium-independent phospholipases A2 beta or gamma inhibits the hormone-induced differentiation of 3T3-L1 preadipocytes, J. Biol. Chem., 279, 21740, 10.1074/jbc.M314166200
Li, 2005, ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery, Am. J. Physiol.: Heart Circ. Physiol., 289, H2592
Pawliczak, 2004, Cytosolic phospholipase A2 Group IV alpha but not secreted phospholipase A2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells, J. Biol. Chem., 279, 48550, 10.1074/jbc.M408926200
Li, 2005, Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D, J. Pharmacol. Exp. Ther., 312, 1043, 10.1124/jpet.104.076588
Tashiro, 2004, B-Myb-dependent regulation of c-Myc expression by cytosolic phospholipase A2, J. Biol. Chem., 279, 17715, 10.1074/jbc.M310561200
Murakami, 2005, Cellular distribution, post-translational modification, and tumorigenic potential of human Group III secreted phospholipase A2, J. Biol. Chem., 280, 24987, 10.1074/jbc.M502088200
Masuda, 2005, Neuronal expression and neuritogenic action of Group X secreted phospholipase A2, J. Biol. Chem., 280, 23203, 10.1074/jbc.M500985200